Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Dizal's recent announcement regarding the FDA's granting of Breakthrough Therapy. The approval stems from compelling data...
Researchers at the University of Pennsylvania devised a breakthrough technique for creating HACs from designer DNA, sidestepping issues with DNA constructs....
Researchers at the Gwangju Institute of Science and Technology Discover a Novel Drug Candidate to Combat Fatty Liver Disease. Metabolic dysfunction-associated steatotic liver disease is a significant global health concern...
Orchard Therapeutics, now part of Kyowa Kirin, has achieved a significant breakthrough with the approval of Lenmeldy™ by the U.S. Food and Drug Administration. Lenmeldy, previously...
A group of researchers at Brown University has devised an innovative approach to swiftly predict diverse protein configurations using machine learning. Their method aims...
The recent approval by the Food and Drug Administration of a novel cellular immunotherapy at Moffitt Cancer Center marks a pivotal moment for patients battling advanced melanoma. This groundbreaking therapy...
Otsuka Pharmaceutical Development & Commercialization, Inc, in collaboration with Otsuka Pharmaceutical Co., Ltd, and Visterra, Inc., an Otsuka group company, jointly announce a significant development: the U.S. Food and Drug Administration...
Nuvalent, a biopharmaceutical company in the clinical stage, has declared that the U.S. Food and Drug Administration has accorded breakthrough therapy designation to NVL-520 for treating individuals...
Iovance Biotherapeutics, a leading biotechnology company committed to pioneering, developing, and delivering innovative polyclonal tumor infiltrating lymphocyte cell therapies for cancer patients...
Alector recently announced a significant milestone in the potential treatment of Frontotemporal Dementia with a progranulin gene mutation. The U.S. Food and Drug Administration...
